Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells.
Ontology highlight
ABSTRACT: MITF (microphthalmia-associated transcription factor) is a frequently amplified lineage-specific oncogene in human melanoma, whose role in intrinsic drug resistance has not been systematically investigated. Utilizing chemical inhibitors for major signaling pathways/cellular processes, we witness MITF as an elicitor of intrinsic drug resistance. To search kinase(s) targets able to bypass MITF-conferred drug resistance, we employed a multi-kinase inhibitor-directed chemical proteomics-based differential affinity screen in human melanocytes carrying ectopic MITF overexpression. A subsequent methodical interrogation informed mitotic Ser/Thr kinase Aurora Kinase A (AURKA) as a crucial regulator of melanoma cell proliferation and migration, independent of the underlying molecular alterations, in
SUBMITTER: Pathria G
PROVIDER: S-EPMC4823922 | biostudies-literature | 2016 Mar
REPOSITORIES: biostudies-literature
ACCESS DATA